ADRA2B Antikörper (Center)
Kurzübersicht für ADRA2B Antikörper (Center) (ABIN7834202)
Target
Alle ADRA2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Center
-
Verwendungszweck
- Rabbit polyclonal antibody to Alpha-2B Adrenergic Receptor
-
Spezifität
- Recognizes endogenous levels of Alpha-2B Adrenergic Receptor protein.
-
Aufreinigung
- The antibody was purified by immunogen affinity chromatography.
-
Immunogen
- KLH-conjugated synthetic peptide encompassing a sequence within the center region of human Alpha-2B Adrenergic Receptor. The exact sequence is proprietary.
-
-
-
-
Applikationshinweise
- WB (1/500 - 1/1000), IH (1/50 - 1/100), IF/IC (1/50 - 1/200)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid in 0.42 % Potassium phosphate, 0.87 % Sodium chloride, pH 7.3, 30 % glycerol, and 0.01 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
-
- ADRA2B (Adrenergic, alpha-2B-, Receptor (ADRA2B))
-
Andere Bezeichnung
- ADRA2B
-
Hintergrund
- ADRA2L1, ADRA2RL1, Alpha-2B adrenergic receptor, Alpha-2 adrenergic receptor subtype C2, Alpha-2B adrenoreceptor, Alpha-2B adrenoceptor, Alpha-2BAR
-
Gen-ID
- 151, 24174
-
UniProt
- P18089
-
Pathways
- EGFR Signaling Pathway, cAMP Metabolic Process
Target
-